1590. Activity of Meropenem-Vaborbactam and Single-Agent Comparators against Enterobacterales Isolates Including KPC-Producing Isolates, from European Patients Hospitalized with Pneumonia Including Ventilator-Associated Pneumonia (2014-2019)

BACKGROUND: Meropenem-vaborbactam (MVB) was recently approved in Europe for the treatment of complicated UTIs, including acute pyelonephritis, complicated intra-abdominal infections, hospital-acquired bacterial pneumonia, ventilator-associated pneumonia (VAP), and bacteremia. KPC-producing Enterobac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shorttidge, Dee, Deshpande, Lalitagauri M, Duncan, Leonard R, Streit, Jennifer M, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777559/
http://dx.doi.org/10.1093/ofid/ofaa439.1770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777559/
http://dx.doi.org/10.1093/ofid/ofaa439.1770

Ejemplares similares